NPB - NYSE
Northpointe Bancshares, Inc.
$17.50
-3.7%Northpointe Bancshares, Inc. operates as the bank holding company for Northpointe Bank provides various banking products and services in the United States. It operates through two segments: Mortgage Purchase Program and Retail Banking. The company offers digital deposit banking, such as noninterest-bearing accounts, savings, money-market demand accounts, and certificates of deposits; personal and business banking; and health saving accounts; home loans; mortgage purchase program; residential mortgage lending; and custodial deposit services. Northpointe Bancshares, Inc. was incorporated in 1998 and is headquartered in Grand Rapids, Michigan.
At a Glance
Live Snapshotnpb
Additional Paid-In Capital
Last Annual Value
204.88M
3-Year CAGR
-72%
5-Year CAGR
-30%
10-Year CAGR
-16%
Northpointe Bancshares, Inc. Competitors Analysis of Additional Paid-In Capital
| Company | Additional Paid-In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Northpointe Bancshares, Inc. NYSE:NPB | 204.88M | -72.5% | -32.2% | N/A | |
 ALX Oncology Holdings Inc. NASDAQ:ALXO | 748.72M | 3.5% | 5.8% | N/A | |
 Legend Biotech Corporation NASDAQ:LEGN | 2.75B | 1.4% | 16.9% | N/A | |
 C4 Therapeutics, Inc. NASDAQ:CCCC | 995.22M | 8.7% | 8.6% | N/A | |
 Erasca, Inc. NASDAQ:ERAS | 1.22B | 9.7% | 11.9% | N/A | |
 Cullinan Therapeutics, Inc. NASDAQ:CGEM | 995.82M | 15.0% | 11.2% | N/A |
Northpointe Bancshares, Inc. Fair Value Envelope
Related Guides
Continue your NPB research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.